Israel Rozen

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Andrew Ashe, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Israel Rozen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Verve Therapeutics, Inc. 10%+ Owner Common Stock 409,626 $4,096,260 $10.00 16 Jun 2021 Direct

Insider Reports Filed by Israel Rozen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VERV Verve Therapeutics, Inc. 16 Jun 2021 0 $0 3 10%+ Owner 16 Jun 2021, 19:38